Problematic issues of topical glucocorticosteroid application in practice of general practitioner

Main Article Content

V.I. Pankiv


The article considers the problematic issues of topical glucocorticosteroid use in practice of general practitioner. It is underlined that manufacturer of the drug plays an important role in the choice of topical glucocorticosteroids: whether the drug is original or generic, as all significant researches on the efficiency and safety are being conducted exac­tly with original preparations. Original medications have the well-proven clinical efficiency and well-studied profile of safety that allows using them without the risk of developing side effects or complications.

Article Details

How to Cite
Pankiv, V. “Problematic Issues of Topical Glucocorticosteroid Application in Practice of General Practitioner”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 1, Mar. 2018, pp. 103-7, doi:10.22141/2224-0721.14.1.2018.127102.
Рoint of view


Stepanenko VI, Korolenko VV, Ivanov SV. Use of topic steroid Mometasone™ in the treatment of allergic dermatoses. Ukrainian Journal of Dermatology, Venerology, Cosmetology. 2010;2(37):114-116. (in Russian).

Baida G, Bhalla P, Kirsanov K, et al. REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids. EMBO Mol Med. 2015 Jan;7(1):42-58. doi: 10.15252/emmm.201404601.

Kishibe M, Baida G, Bhalla P, et al. Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids. Oncotarget. 2016 Oct 25;7(43):69479-69488. doi: 10.18632/oncotarget.9926.

Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013 Oct;45(10):2163-72. doi: 10.1016/j.biocel.2013.05.036.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 12 > >>